Irvine, CA, United States of America

Jianping Gao

USPTO Granted Patents = 3 

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2012-2014

Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovations of Jianping Gao: A Leader in Dry Eye Treatment

Introduction: Jianping Gao is a prominent inventor based in Irvine, CA, who has made significant contributions to the field of ophthalmology through his research and innovations. With three patents to his name, he holds a key role at Allergan, Inc. and is recognized for his groundbreaking work in treatments for conditions such as dry eye.

Latest Patents: Jianping Gao's most notable patents include a method involving a KLK-13 antibody inhibitor aimed at treating dry eye. This innovative approach promises to enhance the quality of life for individuals suffering from this condition, showcasing the potential of targeted antibody therapies in ophthalmic treatments.

Career Highlights: Throughout his career, Jianping Gao has demonstrated a commitment to advancing healthcare solutions through scientific exploration. His work at Allergan, Inc. allows him to collaborate with leading experts in the field, driving research that directly impacts patient care.

Collaborations: Jianping has collaborated with notable colleagues, including Michael E. Stern and Karyn F. Siemasko, who have contributed to the development of his innovative therapies. These partnerships emphasize the collaborative spirit that is essential in the research and development of effective medical solutions.

Conclusion: Jianping Gao's contributions to the medical community, particularly in treating dry eye, highlight the importance of innovation in healthcare. His work, supported by patents that protect his inventions, underscores the vital role that inventors play in improving patient outcomes through new therapies. As the field continues to evolve, Gao's pioneering efforts will likely lead to further advancements in ophthalmic treatments.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…